BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SGC and HitGen Partner for DNA-Encoded Drug Discovery

HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC. &nbs...

September 29, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies

The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...

September 28, 2023 | News

Seven AI/ML Life Sciences Innovators in Clarivate's Watchlist

United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery C...

September 28, 2023 | News

Ascletis Completes Enrollment for Glioblastoma Treatment Trial

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...

September 27, 2023 | News

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...

September 27, 2023 | News

Unlocking Access to Better Hearing Health: New Mobile Fitting Van Hits the Road in China

In a vast and culturally rich nation like China, millions of individuals deserve the opportunity to experience the beauty of sound. The Signia Mobile...

September 26, 2023 | News

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...

September 26, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

September 26, 2023 | News

Chime Biologics Partners with Korea Kings Pharm for Biosimilar Launch

Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...

September 26, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...

September 25, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...

September 25, 2023 | News

Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL

"Patients with relapsed or refractory PTCL worldwide face limited treatment options and a poor prognosis. We are pleased with the CDE's decision to grant p...

September 22, 2023 | News

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...

September 22, 2023 | News

Stay Connected